MWM
GSK icon

Meridian Wealth Management’s GSK GSK Stock Holding History

Meridian Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Sell
6,260
-60
-0.9% -$3.25K 0.01% 616
2025
Q4 		$310K Buy
6,320
+20
+0.3% +$933 0.01% 609
2025
Q3 		$272K Sell
6,300
-176
-3% -$6.88K 0.01% 603
2025
Q2 		$249K Buy
6,476
+305
+5% +$11.7K 0.01% 594
2025
Q1 		$239K Sell
6,171
-5,210
-46% -$191K 0.01% 565
2024
Q4 		$385K Sell
11,381
-2,255
-17% -$81.2K 0.02% 473
2024
Q3 		$557K Sell
13,636
-2,380
-15% -$97.4K 0.03% 390
2024
Q2 		$617K Buy
+16,016
New +$674K 0.07% 156
2024
Q1 		– Sell
-44,686
Closed -$1.66M – 331
2023
Q4 		$1.66M Buy
44,686
+38,211
+590% +$1.37M 0.11% 188
2023
Q3 		$235K Sell
6,475
-1,704
-21% -$60.5K 0.01% 490
2023
Q2 		$292K Sell
8,179
-320
-4% -$11.5K 0.02% 445
2023
Q1 		$302K Sell
8,499
-7
-0.1% -$245 0.03% 420
2022
Q4 		$299K Buy
+8,506
New +$283K 0.03% 414
2022
Q3 		– Sell
-9,298
Closed -$506K – 523
2022
Q2 		$506K Buy
9,298
+3,252
+54% +$180K 0.04% 344
2022
Q1 		$329K Hold
6,046
– – 0.04% 297
2021
Q4 		$333K Buy
6,046
+320
+6% +$16.6K 0.04% 303
2021
Q3 		$274K Buy
5,726
+467
+9% +$23.5K 0.03% 325
2021
Q2 		$262K Buy
+5,259
New +$253K 0.03% 322
2019
Q3 		– Sell
-1,040
Closed -$520 – 300
2019
Q2 		$520 Buy
+1,040
New +$52.2K 0.02% 365

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Meridian Wealth Management's GSK Position: Q1 2026 in Review

Meridian Wealth Management reduced its GSK (GSK) stake by 0.95% in Q1 2026, selling an estimated $3.25K and leaving 6,260 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #616.

Meridian Wealth Management first reported a position in GSK in Q2 2019 and has held it in 19 quarters since. The position peaked at $1.66M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Meridian Wealth Management held 6,260 shares of GSK worth $345K as of Q1 2026.
  • Meridian Wealth Management sold 60 GSK shares in Q1 2026, an estimated $3.25K.
  • GSK made up 0.01% of Meridian Wealth Management's portfolio in Q1 2026, its #616 holding.
  • Meridian Wealth Management first reported a position in GSK in Q2 2019 and has held it in 19 quarters since.
  • Meridian Wealth Management's GSK position peaked at $1.66M in Q4 2023.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.